Similar to CMMRD, patients with LS, who harbor a heterozygous germline mutation in MMR genes and acquire a second mutation somatically, may also develop gastrointestinal tumors and gliomas [34, 35]. This evidence concerns the gene MRC1 and digestive system neoplasm.